Sign In  |  Register  |  About Walnut Creek Guide  |  Contact Us

Walnut Creek, CA
September 01, 2020 1:43pm
7-Day Forecast | Traffic

  • Search Hotels in Walnut Creek Guide

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Gilead Sciences (NQ: GILD )

89.51 +0.69 (+0.78%)
Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Gilead Sciences

< Previous 1 2
...
30 31 32 33 34 35 36 37 38
...
51 52 Next >
Monkeypox Could Reportedly Trigger An Uptick In Sepsis Cases But This Israeli Biotech Company Says It May Have Found A Treatment
As the mysterious monkeypox outbreak has many scientists on heightened alert, the rare virus could pose an additional threat to a global population still reeling from the COVID-19 pandemic. 
Via Benzinga
Why Gilead Is Cheapest Large-Cap Biotech Despite Some Not So Favorable Acquisitions
Even after spending over $40 billion in the past five years on acquisitions, none of the deals for Gilead Sciences Inc (NASDAQ: GILD) has delivered the blockbuster in cancer as it looked to venture... 
Via Benzinga
Analysts Remain Bullish Despite Caribou's Allogeneic CAR-T Hit By Durability
Via Benzinga
Here's How Much $100 Invested In Gilead Sciences 15 Years Ago Would Be Worth Today
Gilead Sciences (NASDAQ:GILD) has outperformed the market over the past 15 years by 1.22% on an annualized basis producing an average annual return of 7.45%. Currently, Gilead Sciences has a market... 
Via Benzinga
What's Next For NRx Pharma As FDA Denies Breakthrough Therapy Tag For COVID-19 Therapy
Via Benzinga
There Are Some Serious Deals In The Market Right Now
Interested in buying high-quality dividend growth stocks on sale? Want to know my top five stocks for June 2022? Then you have to check out this video. 
Via Talk Markets
7 Great ETFs to Buy Now for Momentum in Q2
These seven ETFs to buy are among the best funds. YPS, BITQ, FMET, QQMG, DVY, XSD, and VHT can make excellent investments. 
Via InvestorPlace
Sunshine Biopharma States It Is Developing COVID Antiviral That Could Play Important Role In Treating Endemic COVID
Image provided by Pexels 
Via Benzinga
7 Oversold Stocks to Buy Right Now
Identifying oversold stocks gives investors the opportunity to buy shares that they perhaps already liked, only at a discounted price. 
Via InvestorPlace
Gilead Joining the Global Access to Oncology Medicines Coalition
SOURCE: Gilead Sciences 
Via 3BL Media
Final Data From Phase 3 ASCENT Study Demonstrates Trodelvy Extends Overall Survival Over Chemotherapy in Second-Line Metastatic TNBC
From Gilead Sciences, Inc.
Via Business Wire
Tecartus® Car T-cell Therapy Demonstrates Strong Overall Survival Rates and Continued Durable Responses in Long-Term Follow-Up of Two Pivotal Studies Including Longest Ever Follow-Up of a CAR T-cell Therapy in Mantle Cell Lymphoma
From Gilead Sciences, Inc.
Via Business Wire
Sub-analyses of Landmark ZUMA-7 Trial Reinforce Yescarta® CAR T-cell Therapy Superiority Over Standard of Care (SOC) as Initial Treatment for Patients With Relapsed or Refractory Large B-cell Lymphoma (LBCL)
From Gilead Sciences, Inc.
Via Business Wire
Trodelvy® Improved Progression-Free Survival by 34% in Heavily Pre-Treated HR+/HER2- Metastatic Breast Cancer Patients
From Gilead Sciences, Inc.
Via Business Wire
Yescarta® CAR T-cell Therapy Demonstrates Consistent Survival Outcomes and Safety in Real-World Setting Regardless of Race and Ethnicity
From Gilead Sciences, Inc.
Via Business Wire
Michael Elliott Named to 2022 Empower Advocate Executive Role Model List.
SOURCE: Gilead Sciences 
Via 3BL Media
Gilead Sciences Appoints Stacey Ma, PhD as Executive Vice President, Pharmaceutical Development and Manufacturing
From Gilead Sciences, Inc.
Via Business Wire
June 2022 Stock Considerations
With the start of a new trading month, it is time, once again, to highlight some potential stock buys for June. 
Via Talk Markets
4 Questions With Betty Chiang: Addressing Health Disparities in the Asian Community
SOURCE: Gilead Sciences 
Via 3BL Media
7 Safe Dividend Stocks With High Yields to Buy Now
Investors are seeking dividend stocks. Here are seven safe dividend stocks that offer a high yield to maximize their total return. 
Via InvestorPlace
Portugal's Positive Approach to Teaching Teens about the Birds, Bees and STIs
SOURCE: Gilead Sciences 
Via 3BL Media
Why NRX Pharmaceuticals Shares Are Trading Lower During Premarket On Thursday?
Via Benzinga
Murder For Hire? What You Need To Know About Enochian Biosciences Co-Founder's Arrest
The co-founder of Enochian Biosciences Inc (NASDAQ: ENOB) was arrested Wednesday following a two-year investigation into a man who was kidnapped and found dead in January 2018. 
Via Benzinga
Gilead Reaches Number One Spot as Top Overall Philanthropic Funder of HIV-Related Programs, According to Funders Concerned About AIDS Report
SOURCE: Gilead Sciences 
Via 3BL Media
Recent Stock Purchase May 2022
I have been busy buying up some stock this month and was happy to put some fresh capital to work to try and recoup some of my lost dividend income courtesy of the numerous cuts bestowed upon my... 
Via Talk Markets
Benzinga's Top Ratings Upgrades, Downgrades For May 23, 2022
Via Benzinga
Gilead at Forefront of Herculean Effort to Combat COVID-19
SOURCE: Gilead Sciences 
Via 3BL Media
Gilead Reaches Number One Spot as Top Overall Philanthropic Funder of HIV-Related Programs, According to Funders Concerned About AIDS Report
From Gilead Sciences, Inc.
Via Business Wire
Gilead Stock Earns Rating Upgrade After Quick Turnaround
A Relative Strength Rating upgrade for Gilead stock shows improving technical performance. Will it continue? 
Via Investor's Business Daily
Living with Metastatic Bladder Cancer: Joey's Journey
SOURCE: Gilead Sciences 
Via 3BL Media
Topics Product Recall
Exposures Legal Product Safety
< Previous 1 2
...
30 31 32 33 34 35 36 37 38
...
51 52 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 WalnutCreekGuide.com & California Media Partners, LLC. All rights reserved.